ALPMF - Apellis adds safety warning to eye therapy
2023-12-01 09:18:27 ET
More on Apellis Pharmaceuticals
- Apellis Pharmaceuticals, Inc. (APLS) Q3 2023 Earnings Call Transcript
- Apellis Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Apellis Pharmaceuticals: Looking For Entry Around Crucial Q3 Earnings
- Apellis Pharmaceuticals reports insider transactions worth $1.9M
- Apellis Pharmaceuticals falls amid new short call from Citron Research
For further details see:
Apellis adds safety warning to eye therapy